In this study, infants whose mothers had received n-3 LCPUFAs had less risk of becoming sensitised to egg, less IgE-associated eczema (atopic dermatitis) and less food allergy during the first year of life [74]. Here, IGHE is linked to Eczematoid dermatitis.